|
|
CLIC3 |
chloride intracellular channel 3 |
|
|
|
|
|
CLIP4 |
CAP-Gly domain containing linker protein family member 4 |
|
|
|
|
|
CLK3 |
CDC like kinase 3 |
|
- K-00546
- ethyl 3-[(E)-2-amino-1-cyanoethenyl]-6,7-dichloro-1-methyl-1H-indole-2-carboxylate
- Fostamatinib
|
|
|
|
CLP1 |
cleavage factor polyribonucleotide kinase subunit 1 |
- tRNA processing in the nucleus
- mRNA 3'-end processing
- Processing of Capped Intron-Containing Pre-mRNA
- RNA Polymerase II Transcription Termination
- Processing of Intronless Pre-mRNAs
|
|
|
|
|
CLU |
clusterin |
- Platelet degranulation
- Terminal pathway of complement
- Antimicrobial peptides
- Regulation of Complement cascade
|
- Zinc
- Copper
- Zinc acetate
- Zinc chloride
- Zinc sulfate, unspecified form
|
|
|
|
CLUAP1 |
clusterin associated protein 1 |
- Intraflagellar transport
- Intraflagellar transport
|
|
|
|
|
CMAS |
cytidine monophosphate N-acetylneuraminic acid synthetase |
|
- Cytidine-5'-Monophosphate-5-N-Acetylneuraminic Acid
|
|
|
|
CMTM2 |
CKLF like MARVEL transmembrane domain containing 2 |
|
|
|
|
|
CMTM3 |
CKLF like MARVEL transmembrane domain containing 3 |
|
|
|
|
|
CNDP1 |
carnosine dipeptidase 1 |
|
|
|
|
|
CNOT7 |
CCR4-NOT transcription complex subunit 7 |
- Deadenylation of mRNA
- TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain
- M-decay: degradation of maternal mRNAs by maternally stored factors
|
|
|
|
|
CNPY2 |
canopy FGF signaling regulator 2 |
|
|
|
|
|
COA5 |
cytochrome c oxidase assembly factor 5 |
|
|
- Mitochondrial respiratory chain deficiencies (MRCD), including: Mitochondrial complex I deficiency (MT-C1D); Complex II deficiency (MT-C2D); Complex III deficiency (MT-C3D); Complex IV deficiency (MT-C4D); Complex V deficiency (MT-ATPSD); Leigh syndrome (LS); Kearns-Sayre Syndrome (KSS); LCHD deficiency (LCHD); Leber Hereditary Optic Neuropathy (LHON); Myoclonic Epilepsy and Ragged-Red Fiber Disease (MERRF); NARP; MELAS; ACAD9 deficiency; HADH deficiency; HIBCH deficiency; GRACILE syndrome
|
|
|
COASY |
Coenzyme A synthase |
|
|
|
|
|
COIL |
coilin |
|
|
|
|
|
COL11A1 |
collagen type XI alpha 1 chain |
- Collagen degradation
- Collagen degradation
- Collagen biosynthesis and modifying enzymes
- Assembly of collagen fibrils and other multimeric structures
- Non-integrin membrane-ECM interactions
- MET activates PTK2 signaling
- Collagen chain trimerization
- Developmental Lineage of Pancreatic Ductal Cells
|
|
- Type XI collagenopathies, including: Stickler syndrome type 2; Stickler syndrome type 3; Otospondylomegaepiphyseal dysplasia (OSMED); Marshall syndrome; Weissenbacher-Zweymuller syndrome
- Vitreoretinal degeneration, including: Stickler syndrome type I (STL1); Stickler syndrome type II (STL2); Snowflake vitreoretinal degeneration (SVD); Wagner syndrome 1 (WGN1); Knobloch syndrome (KNO); Enhanced S-cone syndrome (ESCS); Autosomal dominant vitreoretinochoroidopathy (ADVIRC)
|
|
|
COL14A1 |
collagen type XIV alpha 1 chain |
- Collagen degradation
- Collagen biosynthesis and modifying enzymes
- Assembly of collagen fibrils and other multimeric structures
- Collagen chain trimerization
|
|
|
|
|
COL18A1 |
collagen type XVIII alpha 1 chain |
- Collagen degradation
- Activation of Matrix Metalloproteinases
- Collagen biosynthesis and modifying enzymes
- Assembly of collagen fibrils and other multimeric structures
- Integrin cell surface interactions
- Laminin interactions
- Collagen chain trimerization
|
|
- Vitreoretinal degeneration, including: Stickler syndrome type I (STL1); Stickler syndrome type II (STL2); Snowflake vitreoretinal degeneration (SVD); Wagner syndrome 1 (WGN1); Knobloch syndrome (KNO); Enhanced S-cone syndrome (ESCS); Autosomal dominant vitreoretinochoroidopathy (ADVIRC)
- Polymicrogyria; Bilateral frontal polymicrogyria (BFP); Bilateral frontoparietal polymicrogyria (BFPP); Bilateral perisylvian polymicrogyria (BPP); Bilateral parasagittal parieto-occipital polymicrogyria (BPOP); Bilateral generalised polymicrogyria (BGP); Unilateral Polymicrogyria (ULP)
|
|
|
COL1A2 |
collagen type I alpha 2 chain |
- GPVI-mediated activation cascade
- Collagen degradation
- Collagen degradation
- Fibronectin matrix formation
- Collagen biosynthesis and modifying enzymes
- Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell
- Assembly of collagen fibrils and other multimeric structures
- Cell surface interactions at the vascular wall
- Integrin cell surface interactions
- Integrin cell surface interactions
- SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription
- Anchoring fibril formation
- Crosslinking of collagen fibrils
- Syndecan interactions
- Non-integrin membrane-ECM interactions
- ECM proteoglycans
- ECM proteoglycans
- Scavenging by Class A Receptors
- GP1b-IX-V activation signalling
- Interleukin-4 and Interleukin-13 signaling
- Platelet Adhesion to exposed collagen
- Platelet Adhesion to exposed collagen
- Platelet Aggregation (Plug Formation)
- MET activates PTK2 signaling
- Collagen chain trimerization
- Enhanced cleavage of VWF variant by ADAMTS13
- Enhanced binding of GP1BA variant to VWF multimer:collagen
- Defective VWF cleavage by ADAMTS13 variant
- Defective VWF binding to collagen type I
- Defective binding of VWF variant to GPIb:IX:V
- Developmental Lineage of Pancreatic Ductal Cells
|
|
- Osteogenesis imperfecta
- Ehlers-Danlos syndrome (EDS), including: EDS classical type (EDS1/2); EDS hypermobility type (EDS3); EDS vascular type (EDS4); EDS kyphoscoliosis type (EDS6); EDS arthrochalasia type (EDS7A/7B); EDS dermatospraxis type (EDS7C); EDS autosomal recessive cardiac valvular form (EDSCV); EDS musculocontractural type (EDSMC); EDS progeroid form (EDSP); Tenascin-X deficiency (TNXD); Brittle cornea syndrome (EDS6B); EDS-like spondylocheiro dysplasia (SCD-EDS)
|
|
|
COL25A1 |
collagen type XXV alpha 1 chain |
- Collagen degradation
- Collagen biosynthesis and modifying enzymes
- Collagen chain trimerization
|
|
|